Nektar Therapeutics Securities Fraud Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Nektar Therapeutics · REZOLVE-AA trial and rezpegaldesleukin · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Nektar Therapeutics
- Product or service
- REZOLVE-AA trial and rezpegaldesleukin
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Investor contact and case participation
Participation information
Availability is based on each listed participation option and its deadline.
Investor contact and case participation
Investors who purchased Nektar Therapeutics securities between February 26, 2025 and December 15, 2025, inclusive, and suffered a loss.
Contact the Schall Law Firm to discuss rights and potential participation in the lawsuit.
- Type
- Law Firm Signup
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Nektar Therapeutics Securities Fraud Class Action
Barchart.com ·